Á lódáil...
Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
As no specific pharmacological treatment has been validated for use in coronavirus disease 2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these patients at a referral centre in Iran. An open-label, randomised controlled trial was conducted on patients with laboratory-...
Na minha lista:
Foilsithe in: | Int J Antimicrob Agents |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2020
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7445147/ https://ncbi.nlm.nih.gov/pubmed/32853672 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.106143 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|